one more time you are trying to mislead!!!!
this should be fun and will support further the CTDH case
enjoy
Cyclodextrin has been stolen and now sold for $200 million dollars!! It's going to a billion++ dollars when approved. This was a drug funded and created by all of you who helped us.”
Soon after reaching out to the Hempels and agreeing to a joint venture, Cydan formed Vtesse, a company dedicated to developing drugs for Niemann-Pick Disease Type C and other rare diseases. In April 2017, Vtesse was purchased by Sucampo Pharmaceuticals for $200 million, in large part because of the same treatment, the suit says, the Hempels were in contract to develop.
•In December 2017, Sucampo was purchased by Mallinckrodt, a global pharmaceutical company, for $1.2 billion. The press release highlighting the acquisition mentions the development on the cyclodextrin being part of the billion-dollar deal.
"Cydan, Vitesse, and Sucampo swooped in to misappropriate the Hempels' confidential information and trade secrets, developed a directly competitive treatment, and sold it to an international pharmaceutical company for hundreds of millions of dollars," the lawsuit said.
News 
Market Data 
Discover 
